Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) treated with DNMTI therapy have responses according to the 2006 IWG response criteria. CR responses have had the strongest association with OS. Recently, CR with partial hematologic recovery (CRh; i.e. blasts <5%, ANC > 500, platelets > 50) has been evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Andrew M., Gavralidis, Alexander, Ali, Najla Al, Hunter, Anthony, Komrokji, Rami, Zeidan, Amer, Sallman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666661/
https://www.ncbi.nlm.nih.gov/pubmed/36379923
http://dx.doi.org/10.1038/s41408-022-00748-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666661/
https://www.ncbi.nlm.nih.gov/pubmed/36379923
http://dx.doi.org/10.1038/s41408-022-00748-9

Ejemplares similares